Shop
Cart Details

REPATHA- evolocumab injection, solution 140mg/ml

  • Manufacturer Name : AMGEN
  • MFG # : 72511076002
  • NDC : 72511076002
  • Distributor Name : CARDINAL - PHYS OFF Pharm 2025
PID UOM Price Qty
648455 12/CT
$1,136.10
Register For Member Price

 

Description

Indications and Usage:

REPATHA is indicated:

  • In adults with established cardiovascular disease to reduce the risk of myocardial infarction, stroke, and coronary revascularization
  • As an adjunct to diet, alone or in combination with other low-density lipoprotein cholesterol (LDL-C)-lowering therapies, in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), to reduce LDL-C
  • As an adjunct to diet and other LDL-C-lowering therapies in pediatric patients aged 10 years and older with HeFH, to reduce LDL-C
  • As an adjunct to other LDL-C-lowering therapies in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH), to reduce LDL-C

Frequently Asked Questions(FAQs)

The cost of REPATHA- evolocumab injection, solution 140mg/ml is $1,136.10 .
REPATHA- evolocumab injection, solution 140mg/ml is manufactured by AMGEN.
Read More

Subscribe to Our Newsletter